000 01092 a2200301 4500
005 20250513120954.0
264 0 _c19970619
008 199706s 0 0 eng d
022 _a0964-3397
024 7 _a10.1016/s0964-3397(97)80305-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMacConnachie, A M
245 0 0 _aEradication therapy in peptic ulcer disease.
_h[electronic resource]
260 _bIntensive & critical care nursing
_cApr 1997
300 _a121-2 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aAnti-Ulcer Agents
_xtherapeutic use
650 0 4 _aDrug Monitoring
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHelicobacter Infections
_xdrug therapy
650 0 4 _aHelicobacter pylori
650 0 4 _aHumans
650 0 4 _aMetronidazole
_xtherapeutic use
650 0 4 _aPeptic Ulcer
_xdrug therapy
773 0 _tIntensive & critical care nursing
_gvol. 13
_gno. 2
_gp. 121-2
856 4 0 _uhttps://doi.org/10.1016/s0964-3397(97)80305-9
_zAvailable from publisher's website
999 _c9161528
_d9161528